Beractant

ATC R07AA02 · 4 markets · 5 records

Beractant 4 markets · 5 records Forms

AU 2 records · 2 strengths

  • 25 mg/mLliquidSURVANTA beractant (as phospholipids) 200mg/8mL suspension vial unknown

Records without a stated strength · 1 Survanta

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 200 mg/8 mLliquidSurvanta 200mg/8ml endotracheopulmonary suspension bottles

CA 1 records · 1 strengths

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.